Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Rituximab Given in Conjunction With Standard Chemotherapy in Primary Central Nervous System (CNS) Lymphoma

NCT00335140 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.

NCT NCT00335140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00335140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Rituximab Given in Conjunction With Standard Chemotherapy in Primary Central Nervous System (CNS) Lymphoma
Lead sponsor
Eastern Cooperative Oncology Group
Phase
Phase 2
Overall status
Terminated
Start date
August 23, 2007
Completion date
July 31, 2015
Enrollment
26 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma